The Diagnostic Value of Anti-Mullerian Hormone in Early Post Menarche Adolescent Girls with Polycystic Ovarian Syndrome

Kocaay P., ŞIKLAR Z., Buyukfirat S., BERBEROĞLU M.

JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY, cilt.31, sa.4, ss.362-366, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 31 Sayı: 4
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1016/j.jpag.2018.02.126
  • Dergi Adı: JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.362-366
  • Anahtar Kelimeler: Polycystic ovarian syndrome, Anti-Mullerian hormone, Adolescence, Diagnosis, PCOS SOCIETY CRITERIA, INHIBITING SUBSTANCE, ANDROGEN EXCESS, SERUM-LEVELS, WOMEN, MARKER, RISK, AGE
  • Ankara Üniversitesi Adresli: Evet

Özet

Study Objective: Polycystic ovarian syndrome (PCOS) is a common endocrine disorder characterized by hyperandrogenism and chronic anovulation, which affects 5%-10% of reproductive-age women. Diagnosis of adult patients with PCOS is made easily with clinical and laboratory methods and the anti-Mullerian hormone (AMH) level are accepted as a good indicator. However, there is still no complete consensus on the diagnosis of PCOS in adolescents.